Clinical Trials Logo

Change in Bone Mineral Density clinical trials

View clinical trials related to Change in Bone Mineral Density.

Filter by:
  • Active, not recruiting  
  • Page 1

NCT ID: NCT05461573 Active, not recruiting - Contraception Clinical Trials

Efficacy, Safety, and Tolerability of LPRI-CF113 as an Oral Contraceptive in Females

Start date: August 2, 2022
Phase: Phase 3
Study type: Interventional

This study will be in two parts, Part A and Part B. The primary objective of Part A is to evaluate the contraceptive efficacy of LPRI-CF113. The secondary objective of Part A is to evaluate the safety and tolerability of LPRI-CF113. The primary objective of Part B is to evaluate the impact of LPRI-CF113 on bone mineral density (BMD) at the lumbar spine (L1-L4) after 12 months (13 medication cycles). The secondary objective of Part B is to evaluate the impact of LPRI-CF113 on BMD and bone turnover after 12 months (13 medication cycles) at the femoral neck, total hip, and total body.